Evaluation of the potential of a simplified co-delivery system with oligodeoxynucleotides as a drug carrier for enhanced antitumor effect

References

• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin20156552925559415
   PubMed Web of Science ®Google Scholar
• GandhiNSTekadeRKChouguleMBNanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advancesJ Control Release201419423825625204288
   PubMed Web of Science ®Google Scholar
• LiJWangYZhuYOupickýDRecent advances in delivery of drug–nucleic acid combinations for cancer treatmentJ Control Release201317258960023624358
   PubMed Web of Science ®Google Scholar
• HuCMZhangLNanoparticle-based combination therapy toward overcoming drug resistance in cancerBiochem Pharmacol2012831104111122285912
   PubMed Web of Science ®Google Scholar
• NakamuraKAbu LilaASMatsunagaMDoiYIshidaTKiwadaHA double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNAMol Ther2011192040204721878904
   PubMed Web of Science ®Google Scholar
• DavidsonBLMcCrayPBJrCurrent prospects for RNA interference-based therapiesNat Rev Genet20111232934021499294
   PubMed Web of Science ®Google Scholar
• ElbashirSMLendeckelWTuschlTRNA interference is mediated by 21- and 22-nucleotide RNAsGenes Dev20011518820011157775
   PubMed Web of Science ®Google Scholar
• VilarETaberneroJMolecular dissection of microsatellite instable colorectal cancerCancer Discov2013350251123454900
   PubMed Web of Science ®Google Scholar
• WuSYLopez-BeresteinGCalinGASoodAKRNAi therapies: drugging the undruggableSci Transl Med20146240ps7
   PubMed Web of Science ®Google Scholar
• FatemianTOthmanIChowdhuryEHStrategies and validation for siRNA-based therapeutics for the reversal of multi-drug resistance in cancerDrug Discov Today201419717823974068
   PubMed Web of Science ®Google Scholar
• XiongXBLavasanifarATraceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicinACS Nano201155202521321627074
   PubMed Web of Science ®Google Scholar
• SalzanoGRiehleRNavarroGPercheFDe RosaGTorchilinVPPolymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancerCancer Lett201434322423124099916
   PubMed Web of Science ®Google Scholar
• SalzanoGNavarroGTrivediMSDe RosaGTorchilinVPMultifunctional polymeric micelles co-loaded with anti-survivin siRNA and paclitaxel overcome drug resistance in an animal model of ovarian cancerMol Cancer Ther2015141075108425657335
   PubMed Web of Science ®Google Scholar
• YuDWuFLiuYLiuHXiaQBcl-2 gene silence enhances the sensitivity toward 5-Fluorouracil in gastric adenocarcinoma cellsBiomed Pharmacother20136761561923684481
   PubMed Web of Science ®Google Scholar
• TsourisVJooMKKimSHKwonICWonYYNano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancersBiotechnol Adv2014321037105024924617
   PubMed Web of Science ®Google Scholar
• QianJXuMSuoAFolate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapyActa Biomater20151510211625545322
   PubMed Web of Science ®Google Scholar
• DvorakHFTumor stroma, tumor blood vessels, and antiangiogenesis therapyCancer J20152123724326222073
   PubMed Web of Science ®Google Scholar
• GatsonNNChioccaEAKaurBAnti-angiogenic gene therapy in the treatment of malignant gliomasNeurosci Lett2012527627022906922
   PubMed Web of Science ®Google Scholar
• ChenSFengJMaLLiuZYuanWRNA interference technology for anti-VEGF treatmentExpert Opin Drug Deliv2014111471148024898870
   PubMed Web of Science ®Google Scholar
• ZhaoJZhangZZhaoNMaBAFanQYVEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathwayCell Biochem Biophys20157351952527352347
   PubMed Web of Science ®Google Scholar
• CarmelietPVEGF as a key mediator of angiogenesis in cancerOncology20056941016301830
   PubMed Web of Science ®Google Scholar
• FerraraNHillanKJGerberHPDiscovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNat Rev Drug Discov2004339140015136787
   PubMed Web of Science ®Google Scholar
• ChangJHGargNKLundeEHanKYJainSAzarDTCorneal neovascularization: an anti-VEGF therapy reviewSurv Ophthalmol20125741542922898649
   PubMed Web of Science ®Google Scholar
• ChenYBathulaSRLiJHuangLMultifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancerJ Biol Chem2010285226392265020460382
   PubMed Web of Science ®Google Scholar
• LiuTWangMWangTYaoYZhangNCo-delivery of doxorubicin and siRNA by a simplified platform with oligodeoxynucleotides as a drug carrierColloids Surf B Biointerfaces201512653154025618822
   PubMed Web of Science ®Google Scholar
• WhiteheadKALangerRAndersonDGKnocking down barriers: advances in siRNA deliveryNat Rev Drug Discov2009812913819180106
   PubMed Web of Science ®Google Scholar
• PanwarNYangCYinFYoonHSChuanTSYongKTRNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehiclesNanotechnology20152636510126291710
   PubMed Web of Science ®Google Scholar
• KumarKVulugundamGJaiswalPKShyamlalBRKChaudharySEfficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticlesBioorg Med Chem Lett2017274288429328838699
   PubMed Web of Science ®Google Scholar
• LiYLiuRYangJMaGZhangZZhangXDual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapyBiomaterials2014359731974525189519
   PubMed Web of Science ®Google Scholar
• ButtAMAminMCKatasHAbdul MuradNAJamalRKesharwaniPDoxorubicin and siRNA codelivery via chitosan-coated pH-responsive mixed micellar polyplexes for enhanced cancer therapy in multidrug-resistant tumorsMol Pharm2016134179419027934479
   PubMed Web of Science ®Google Scholar
• HanMLvQTangXOvercoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complexJ Control Release201216313614422940126
   PubMed Web of Science ®Google Scholar
• ZhangSZhaoBJiangHWangBMaBCationic lipids and polymers mediated vectors for delivery of siRNAJ Control Release200712311017716771
   PubMed Web of Science ®Google Scholar
• KanastyRDorkinJRVegasAAndersonDDelivery materials for siRNA therapeuticsNat Mater20131296797724150415
   PubMed Web of Science ®Google Scholar
• XiaYXuTWangCNovel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapyInt J Nanomedicine20171314315929317822
   PubMed Web of Science ®Google Scholar
• LiuFFengLZhangLZhangXZhangNSynthesis, characterization and antitumor evaluation of CMCS–DTX conjugates as novel delivery platform for docetaxelInt J Pharm2013451414923608199
   PubMed Web of Science ®Google Scholar
• LuoKLiCLiLSheWWangGGuZArginine functionalized peptide dendrimers as potential gene delivery vehiclesBiomaterials2012334917492722484048
   PubMed Web of Science ®Google Scholar